Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders

Archives of Neurology

Volumn 55, Issue 10, 1998, Pages 1299-1304

  Kish, Stephen J ^a   Lopes Cendes, Iscia ^b   Guuman, Mark ^c   Furukawa, Yoshiahi ^d   Pandolfo, Massimo ^e   Rouleau, Guy A ^f   Ross, Brian M ^a   Nance, Martha ^b   Schut, Lawrence ^c   Lee, Ang ^d   Distefano, Linda ^e  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Centre de Recherche Louis Charles Simard

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e UNIVERSITY OF MINNESOTA   (United States)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CAUDATE NUCLEUS; CEREBELLAR ATAXIA; CHILD; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FEMALE; GENETIC SUSCEPTIBILITY; GLYCOLYSIS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; INFANT; MACHADO JOSEPH DISEASE; MALE; MICHAELIS CONSTANT; NERVE CELL NECROSIS; NEWBORN; PRIORITY JOURNAL; TEMPORAL CORTEX; TISSUE DISTRIBUTION; TRINUCLEOTIDE REPEAT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCERALDEHYDE 3-PHOSPHATE; HUMANS; INFANT; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; OXIDOREDUCTASES; POINT MUTATION; POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEATS;

EID: 0031695127     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.10.1299     Document Type: Article

References (29)

1. Zhuchenko 0, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated v/ith small polyglutamine expansions in thé au-voltagedependent calcium channel. Nat Genet. 1997;15:62-69.
2. David J, Durr A, Stevanin G, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genêt. 1998;7:165-170.
3. Burke, JR. Enghild JJ, Martin ME, et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med. 1996:2:347-350.
4. Koshy B, MatillaT, Burright EN, et al. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet. 1996:5:1311-1318.
5. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang D-M. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in ageinduced apoptosis in mature cerebellar neurons in culture. J Neurochem. 1996:66:928-935.
6. Ishitani R, Chuang DM. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Nat/AcadSci US A. 1996:93:99379941.
7. Saunders PA, Chaleck-Franaszek E, Chuang D-M. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem. 1997:69:1820-1828.
8. Chuang D-M, Ishitani R. A role for GAPDH in apoptosis and neurodegeneration. Nat Med. 1996:2:609-610.
9. Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996; 271:1423-1427.
10. Bovven DM, Spillane JA, Curzon G, et al. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet. 1979:1:11-14.
11. Lamarche JB, Lemieux B, Lieu HB. The neuropathology of "typical" Friedreich's ataxia in Quebec. Can J Neurol Sei. 1984:11:592-600.
12. Robitaille Y, Schul L, Kish SJ. Structural and immunocytochemical features of SCA-1 -linked olivopontocerebellar atrophy define a unique phenotype. Acta Neuwpathol (Berl). 1995:90:572-581.
13. Mastrogiacomo F, LaMarche J, Dozic S, et al. Immunoreactive levels of aketoglutarate dehydrogenase submits in Friedreich's ataxia and spinocerebellar ataxia type 1. fJeurodegeneration. 1996:5:27-33.
14. Mastrogiacomo F, Bergeron C, Kish SJ. Brain a-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. JfJeurochem. 1993:61:2007-2014.
15. Kish SJ, Shannak K, Hornykiewicz 0. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N EnglJ Med. 1988: 318:867-880.
16. Riley HA. An Atlas of the Basal Ganglia, Brainstem and Spinal Cord. New York, NY: Hafner; 1960.
17. Vyas I, Lowndes HE, Howland RD. Inhibition of glyceraldehyde-3-phosphate dehydrogenase in tissues of the rat by acrylamide and related compounds. Neurotoxicology. 1985:6:123-132.
18. Sabri Ml, Ochs S. Inhibition of glyceraldehyde-3-phosphate dehydrogenase in mammalian nerve by iodoacetic acid. JNeurochem. 1971;18:1509-1514.
19. Mizuno Y, Ohta K. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brain. JfJeurochem. 1986; 46:1344-1352.
20. Browne SE, Bowling AC, MacGarvey U, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann fJeurol. 1997;41:646-653.
21. Prinze C, Dubbelman TM, Van Steveninck J. Protein damage, induced by small amounts of photodynamically generated singlet oxygen or hydroxyl radicals. Biochim Biophys Acta. 1990;169:265-271.
22. Messmer UK, Brüne B. Modification of macrophage glyceraldehyde-3phosphate dehydrogenase in response to nitric oxide. Eur JPharmacol. 1996; 302:171-182.
23. Brannon Thomas L, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol. 1995:133:265-272.
24. Dragunow M, Faull RLM, Lawlor P, et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport. 1995:6:1053-1057.
25. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. JNeurosci. 1995:15:3775-3787.
26. Ledoux S, Desjardins P, Robitaille Y, Kish SJ. Evidence for in situ fragmentation in spinocerebellar type 1 ataxia substantia nigra [abstract). Neurology. 1997;48: A176.
27. Li X-J, Sharp AH, Li S-H, Dawson TM, Snyder SH, Ross CA. Huntingtinassociated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. ProcNatlAcadSciUSA. 1996:93:49394844.
28. Servadio A, Koshy B, Armstrong D, Qantalffy B, Orr HT, Zoghbi HY. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet. 1995;10:94-98.
29. Paulson HL, Das SS, Crino PB, et al. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann eurol. 1997;41:453-462.